CXCR4 antagonist 6
CXCR4 antagonist 6 (compound 46) is a potent CXCR4 antagonist with an IC50 value of 79 nM. CXCR4 antagonist 6 inhibits CXCL12 induced cytosolic calcium flux (IC50 = 0.25 nM) . CXCR4 antagonist 6 significantly mitigates CXCL12/CXCR4 mediated cell migration. CXCR4 antagonist 6 exhibits marked efficacy in a cancer metastasis model in mice[1].
Product Specifications
CAS Number
[2304750-68-1]
UNSPSC
12352005
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cxcr4-antagonist-6.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=CN=C1[C@@H]2CCCN2CC3=NC(C)=NC(N4CCN(CC4)C)=C3
Molecular Formula
C21H30N6
Molecular Weight
366.50
References & Citations
[1]Li Z, et al. Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity. Eur J Med Chem. 2020;205:112537.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS712340-01 0.1 mL
Rabbit anti-human mediator complex subunit 19 polyclonal Antibody
Ask
View Details 
MBS712340-02 5x 0.1 mL
Rabbit anti-human mediator complex subunit 19 polyclonal Antibody
Ask
View Details 035005-FITC 200 µL
EIF3G, ID (EIF3G, EIF3S4, Eukaryotic translation initiation factor 3 subunit G, Eukaryotic translation initiation factor 3 RNA-binding subunit, Eukaryotic translation initiation factor 3 subunit 4, eIF-3-delta, eIF3 p42, eIF3 p44) (FITC) discontinued
Ask
View Details